Kelun Pharmaceutical (002422.SZ) — market event timeline
nashnova tracks 1 market event mentioning Kelun Pharmaceutical (002422.SZ) as of 2026-11-20, each with a dated one-line analysis of how the event relates to the asset.
- CorenBiotech/Merck TROP2 ADC Achieves OS Primary Endpoint in Phase III Gastroesophageal Adenocarcinoma Study
Parent company of CorenBiotech (holding ~60% stake). ADC milestone revenue and valuation uplift at the subsidiary level directly flow through to the parent.
For research and information only — not investment advice.